Trial Profile

Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia.

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 10 Nov 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs F 14512 (Primary) ; Cytarabine
Indications Acute myeloid leukaemia
Focus Adverse reactions; Therapeutic Use
Sponsors Pierre Fabre

Most Recent Events

15 Feb 2018 Status changed from recruiting to discontinued.
21 Oct 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com